Skip to main content

Hemophilia B News (Page 2)

FDA Approves Alprolix (recombinant coagulation factor IX) for patients with Hemophilia B

March 28, 2014 – The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. Alprolix...

FDA Approves Rixubis - First Recombinant Coagulation Factor IX For Use in Preventing Bleeding Episodes

June 27, 2013 – The U.S. Food and Drug Administration yesterday approved Rixubis [Coagulation Factor IX (Recombinant)] for use in people with hemophilia B who are 16 years of age and older. Rixubis...

Ask a question

To post your own question to our community, sign in or create an account.